Private equity firm Cinven is considering a sale of German software company think-cell, which could be valued at as much as €3 billion ($3.5 billion) in a deal, according to people familiar with the ...

Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting a potential link between its use during pregnancy and the development of ...

The maker of Tylenol is pushing back against a request to change its safety label. Here's why. Trump tells Democrats to ‘do something’ ahead of ObamaCare premiums spike FBI arrests 14 current, former ...